Texas Expands Right-to-Try Laws to Include Investigational Stem Cell Treatments

June 27, 2017
Drugs Regulatory Affairs
Texas enacted a law that will allow chronic and terminally ill patients access to stem cell therapies that are unapproved by the FDA.

To View This Article:

Login

Subscribe To FDAnews

Upcoming Events

Featured Products

Featured Stories

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More